Enyedy Mark J — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Enyedy Mark J has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Profile

Enyedy Mark J

Mark J. Enyedy is a corporate executive known for his role as a director at Charles River Laboratories International, Inc. and BioMarin Pharmaceutical Inc. He has extensive experience in the pharmaceutical and biotechnology sectors, contributing to the development of drug discovery and development services.

RoleDirector
Notability50/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-04BMRNBIOMARIN PHARMACEUTICAL INCA — Grant or award7.5K$0.00
2026-05-11CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A — Grant or award1.4K$177.62$255K
2025-06-02CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A — Grant or award946$135.04$128K
2025-05-20BMRNBIOMARIN PHARMACEUTICAL INCA — Grant or award6.7K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Enyedy Mark J?

Mark J. Enyedy is a corporate executive known for his role as a director at Charles River Laboratories International, Inc. and BioMarin Pharmaceutical Inc. He has extensive experience in the pharmaceutical and biotechnology sectors, contributing to the development of drug discovery and development services.…

How many SEC Form 4 filings has Enyedy Mark J submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Where can I see all of Enyedy Mark J's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Enyedy Mark J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.